Cannabis shows promise for cancer symptom management but evidence gaps persist

Cannabis has reasonable evidence for treating nausea, vomiting, appetite loss, and pain in cancer patients, with promising but limited data for neuropathy, GI distress, and sleep problems.

Kleckner, Amber S et al.·Therapeutic advances in medical oncology·2019·Moderate EvidenceNarrative Review
RTHC-02110Narrative ReviewModerate Evidence2019RETHINKTHC RESEARCH DATABASErethinkthc.com/research

Quick Facts

Study Type
Narrative Review
Evidence
Moderate Evidence
Sample
Not reported

What This Study Found

The review found reasonable evidence to consider cannabis for nausea/vomiting, appetite loss, and pain as supplemental treatment. Promising but insufficient evidence exists for chemotherapy-induced peripheral neuropathy, GI distress, and sleep disorders. Evidence for cognitive impairment, anxiety, depression, and fatigue remains scant.

Key Numbers

The review assessed cannabis evidence across at least nine symptom categories in cancer patients, finding reasonable evidence for three (nausea/vomiting, appetite loss, pain) and promising evidence for three more (neuropathy, GI distress, sleep).

How They Did This

Literature review across cancer, HIV, multiple sclerosis, IBD, PTSD, and other fields to inform cannabis use in cancer supportive and palliative care.

Why This Research Matters

Cancer patients are among the highest-use populations for medical cannabis, yet oncologists often lack guidance on what cannabis can and cannot do for their patients' symptoms.

The Bigger Picture

By pulling evidence from multiple disease contexts, this review builds a more complete picture of cannabis's potential in cancer care than studies limited to oncology alone. The multifaceted symptom relief potential is notable for patients dealing with multiple concurrent symptoms.

What This Study Doesn't Tell Us

Narrative review without systematic search methodology. Draws on evidence from non-cancer populations which may not directly translate. Cannabis preparation and dosing varied widely across included studies.

Questions This Raises

  • ?Which cannabis formulations and delivery methods are best suited for specific cancer symptoms?
  • ?Can cannabis reduce the polypharmacy burden that many cancer patients face?

Trust & Context

Key Stat:
3 symptoms with reasonable evidence
Evidence Grade:
Moderate: broad review across multiple conditions, but narrative rather than systematic.
Study Age:
Published in 2019.
Original Title:
Opportunities for cannabis in supportive care in cancer.
Published In:
Therapeutic advances in medical oncology, 11, 1758835919866362 (2019)
Database ID:
RTHC-02110

Evidence Hierarchy

Meta-Analysis / Systematic Review
Randomized Controlled Trial
Cohort / Case-Control
Cross-Sectional / ObservationalSnapshot without intervening
This study
Case Report / Animal Study

Summarizes existing research without a strict systematic method.

What do these levels mean? →

Frequently Asked Questions

What cancer symptoms does cannabis help with most?

The strongest evidence supports cannabis for nausea and vomiting, loss of appetite, and pain in cancer patients.

Can cannabis help with chemo-induced neuropathy?

Promising evidence exists, but the research is too limited to make firm recommendations at this time.

Read More on RethinkTHC

Cite This Study

RTHC-02110·https://rethinkthc.com/research/RTHC-02110

APA

Kleckner, Amber S; Kleckner, Ian R; Kamen, Charles S; Tejani, Mohamedtaki A; Janelsins, Michelle C; Morrow, Gary R; Peppone, Luke J. (2019). Opportunities for cannabis in supportive care in cancer.. Therapeutic advances in medical oncology, 11, 1758835919866362. https://doi.org/10.1177/1758835919866362

MLA

Kleckner, Amber S, et al. "Opportunities for cannabis in supportive care in cancer.." Therapeutic advances in medical oncology, 2019. https://doi.org/10.1177/1758835919866362

RethinkTHC

RethinkTHC Research Database. "Opportunities for cannabis in supportive care in cancer." RTHC-02110. Retrieved from https://rethinkthc.com/research/kleckner-2019-opportunities-for-cannabis-in

Access the Original Study

Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.

This study breakdown was produced by the RethinkTHC research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.